PHIO PHARMACEUTICALS CORP.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $231.0K | $13.0M | $14.3M |
| FY2021 | $0 | $21.9M | $24.1M |
| FY2022 | — | $10.8M | $11.8M |
| FY2023 | — | $7.7M | $8.5M |
| FY2024 | — | $4.7M | $5.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $231.0K | $13.0M | $14.3M |
| FY2021 | $0 | $21.9M | $24.1M |
| FY2022 | — | $10.8M | $11.8M |
| FY2023 | — | $7.7M | $8.5M |
| FY2024 | — | $4.7M | $5.4M |